Article

Richard Lindstrom, MD: "Building" on ophthalmic innovation

Listen as Gil Kliman, MD, managing director of InterWest Partners, interviews Richard Lindstrom, MD, in a one-on-interview at the 2014 Glaucoma 360 meeting. Dr. Lindstrom recalls how he was primed as a boy for the construction business by his father, but decided to go to medical school. The decision catapulted Dr. Lindstrom’s career as ophthalmologist, surgeon, and product innovator.

 

Richard Lindstrom, MD, (right) discusses ophthalmic innovations with Gil Kilman, MD, during their one-on-one interview. (Photo by Stevan Nordstrom)“I’m probably the only person to have a father angry that his son went to medical school,” quipped Richard L. Lindstrom, MD. As part of a one-on-one interview with Gil Kliman, MD, managing director of InterWest Partners, Dr. Lindstrom recalled how he was primed as a boy for the construction business by his father, before medicine chose him during an honors student mentorship at the University of Minnesota. Dr. Lindstrom was persuaded to go to medical school. The decision catapulted Dr. Lindstrom’s career as ophthalmologist, surgeon, and product innovator. Listen to Dr. Kliman’s interview with ophthalmology’s most innovative and influential opinion leader. Listen to Dr. Kliman's complete interview with Dr. Lindstrom. Also, watch as Dr. Lindstrom discusses the advancements in glaucoma over his 40-year career in ophthalmology.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.